Search icon

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.

Company Details

Name: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC.
Jurisdiction: New York
Legal type: FOREIGN NOT-FOR-PROFIT CORPORATION
Status: Active
Date of registration: 08 Dec 2000 (24 years ago)
Entity Number: 2581999
ZIP code: 10036
County: New York
Place of Formation: Delaware
Address: ATTN: MARY E. MCDONALD, ESQ., 1133 AVENUE OF THE AMERICAS, NEW YORK, NY, United States, 10036

DOS Process Agent

Name Role Address
C/O PATTERSON BELKNAP WEBB & TYLER LLP DOS Process Agent ATTN: MARY E. MCDONALD, ESQ., 1133 AVENUE OF THE AMERICAS, NEW YORK, NY, United States, 10036

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
CA1RNRESAZU6
CAGE Code:
52VM4
UEI Expiration Date:
2024-06-29

Business Information

Activation Date:
2023-07-03
Initial Registration Date:
2008-05-12

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
52VM4
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-06-18
CAGE Expiration:
2029-06-18
SAM Expiration:
2025-06-16

Contact Information

POC:
ANA MARIA HARKINS
Phone:
+1 917-715-1605
Fax:
+1 212-227-7541

Form 5500 Series

Employer Identification Number (EIN):
134128413
Plan Year:
2019
Number Of Participants:
66
Sponsors Telephone Number:
Plan Year:
2018
Number Of Participants:
63
Sponsors Telephone Number:
Plan Year:
2017
Number Of Participants:
58
Sponsors Telephone Number:
Plan Year:
2016
Number Of Participants:
52
Sponsors Telephone Number:
Plan Year:
2015
Number Of Participants:
52
Sponsors Telephone Number:

Filings

Filing Number Date Filed Type Effective Date
001208000461 2000-12-08 APPLICATION OF AUTHORITY 2000-12-08

USAspending Awards / Contracts

Procurement Instrument Identifier:
75N93024C00008
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2024-05-10
Total Dollars Obligated:
2475623.00
Current Total Value Of Award:
2475623.00
Potential Total Value Of Award:
9851406.00
Description:
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
Naics Code:
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product Or Service Code:
AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Procurement Instrument Identifier:
HHSF223201510094C
Award Or Idv Flag:
AWARD
Award Type:
DCA
Awarding Agency Name:
Department of Health and Human Services
Performance Start Date:
2015-08-26
Description:
IGF::CL::IGF BAA CONTRACT TITLED, "CONSORTIUM FOR TB BIOMARKERS BIOREPOSITORY."
Naics Code:
541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product Or Service Code:
AZ11: R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH)

USAspending Awards / Financial Assistance

Date:
2024-09-09
Awarding Agency Name:
Department of Defense
Transaction Description:
HOST-DIRECTED APPROACHES TO TARGET GRANULOMA PATHWAYS FOR TREATMENT SHORTENING IN TUBERCULOSIS
Obligated Amount:
7352643.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2024-06-26
Awarding Agency Name:
Department of Defense
Transaction Description:
HOST-DIRECTED PROTEOLYSIS-TARGETING CHIMERA (PROTAC) APPROACH TO TARGET INTRACELLULAR MYCOBACTERIUM TUBERCULOSIS (MTB). CHANGE THE START DATE. ALL OTHER TERMS AND CONDITIONS STILL APPLY.
Obligated Amount:
215429.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2021-09-17
Awarding Agency Name:
Agency for International Development
Transaction Description:
THE TB ALLIANCE ACTIVITY WILL SUPPORT RESEARCH STUDIES TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL TB DRUGS AND TREATMENT REGIMENS, INCLUDING THE DEVELOPMENT AND REGULATORY AUTHORITY APPROVAL OF COMPOUNDS OR REGIMENS IN CLINICAL PHASE DEVELOPMENT. THE GOAL OF THIS ACTIVITY IS TO SUPPORT THE DISCOVERY OF BETTER, FASTER-ACTING, AND AFFORDABLE TB DRUGS.
Obligated Amount:
26000000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2019-04-01
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
MODULATION OF PROTEIN PRODUCTION AND DEGRADATION AS AN INTEGRATED APPROACH TO RAPID STERILIZATION OF DRUG SENSITIVE AND RESISTANT MTB.
Obligated Amount:
28468134.09
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2012-03-08
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
CONSORTIUM FOR TB BIOMARKERS
Obligated Amount:
2216385.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
90853289
Mark:
XTEMP-D
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK
Application Filing Date:
2021-07-28
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
XTEMP-D

Goods And Services

For:
pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
International Classes:
010 - Primary Class
Class Status:
Active
Serial Number:
90853283
Mark:
XTEMP-E
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK
Application Filing Date:
2021-07-28
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
XTEMP-E

Goods And Services

For:
pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
International Classes:
010 - Primary Class
Class Status:
Active
Serial Number:
90853279
Mark:
XTEMP-R
Status:
FOURTH EXTENSION - GRANTED
Mark Type:
TRADEMARK
Application Filing Date:
2021-07-28
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
XTEMP-R

Goods And Services

For:
pharmaceuticals dispensing device used to dissolve solid dosage forms in liquid form
International Classes:
010 - Primary Class
Class Status:
Active

Tax Exempt

Employer Identification Number (EIN) :
13-4128413
In Care Of Name:
% ANGELA VANDERPLOEG
Classification:
Scientific Organization
Ruling Date:
2000-09
National Taxonomy Of Exempt Entities:
Medical Research: Specifically Named Diseases Research
Deductibility:
Type of organization and use of contribution: A public charity. Deductibility Limitation: 50% (60% for cash contributions)

Date of last update: 30 Mar 2025

Sources: New York Secretary of State